News AbbVie loses bid to block 340B law in Mississippi Battle lines are being drawn on 340B rebates as AbbVie loses a bid to block a Mississippi law seeking to retain discounts for contract pharmacies.
News HHS, FDA drop major DTC advertising policy changes HHS and FDA announced a new policy change that would require pharma companies to list drug information much more extensively in broadcast ads.
News FDA lends a hand to Novo, Lilly on illegal GLP-1 imports The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.
News Massachusetts bucks HHS, issuing its own COVID guidelines The Bay State is the first to require insurers to cover the shot for everyone, despite conflicting guidance from RFK's HHS on who should get the jab.
News FDA releases previously unseen CRLs in transparency push The FDA's earlier decision to publish complete response letters was largely a repackaging of existing information, but now it has gone much further.
News RFK faces bipartisan pressure at fractious hearing In a three-hour hearing before the Finance Committee, Senators took RFK to task about CDC ousting and broken promises about the COVID-19 vaccine.
News Alzheimer's biotech Korsana to go public via reverse merger By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer's.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.